GLP - 1 weight - loss drugs

搜索文档
Hershey vs. Mondelez: Which Stock Wins Chocolate Season?
MarketBeat· 2025-09-25 20:02
It’s no surprise that The Hershey Company NYSE: HSY and Mondelez International NASDAQ: MDLZ are lagging the broader market in 2025. However, it’s worth noting that Hershey stock has outperformed Mondelez nearly 2:1 this year. This comes despite rising cocoa prices that impact both companies. Cocoa prices may be beyond the companies’ control, but how each manages rising costs sets them apart. With Halloween and the holidays driving peak candy demand, the strength of their non-chocolate portfolios could deter ...
No more need for needles: A new generation of GLP-1 weight-loss drugs in pill form is coming closer
WSJ· 2025-09-18 14:00
行业动态 - GLP-1药物制造商即将推出每日口服减肥药作为每周注射疗法的替代方案 [1] - 涉及企业包括诺和诺德(Novo Nordisk)与礼来(Eli Lilly) [1] 产品进展 - 每日口服剂型减肥药研发已接近完成阶段 [1] - 新剂型旨在提供更便捷的用药选择 [1]
McDonald's Settles $10B Lawsuit: Should You Buy Now or Hold Steady?
ZACKS· 2025-06-16 14:06
法律纠纷解决 - 麦当劳与媒体大亨Byron Allen达成保密和解 原诉讼涉及100亿美元种族歧视广告指控[1][2] - 和解条款包括在Allen旗下平台按"市场费率"投放广告 消除法律风险同时履行多元化承诺[2] 增长驱动因素 - 美国市场推出McValue平台 国际市场推行每日平价菜单和套餐组合以提升客流量[3] - 成立全球餐厅体验团队整合跨部门资源 加速牛肉 鸡肉 饮料三大品类创新[4] - 物联网设备和谷歌云技术投入提升运营效率 Minecraft电影营销和McCrispy新品强化品牌吸引力[4][5] 财务表现与估值 - 2025年EPS共识预期从12.22美元上调至12.25美元 反映分析师信心增强[7][9] - 当前季度EPS预测3.14美元 2026年预期13.19美元 2025年盈利预计增长4.5%[9][11] - 远期市盈率23.81倍低于行业平均25.91倍 但股价月跌5.2%且低于50日均线[15][17][18] 行业竞争格局 - 面临BJ's Restaurants(预期增长29.9%) Chipotle(8%) CAVA(38.1%)等对手竞争[11] - 通过CosMc's饮品概念和垂直品类团队专注策略应对竞争 尤其在饮料领域寻求突破[6] 宏观挑战 - 美欧市场通胀导致Q1同店销售额下降3.6% 中低收入客群消费力减弱[12] - 牛肉 劳动力和包装成本上涨 欧洲运营利润率受高通胀挤压[13] - GLP-1减肥药物可能改变消费习惯 拖累快餐行业整体情绪[14]